In this study, we develop a test that can predict whether a patient has prostate cancer and how aggressive that cancer is.
This test combines clinical measurements, levels of four genes collected from a fraction of the urine, and levels of six peptides found in urine. We found that this test, deemed ‘ExoSpec’, has the potential to improve the pathway for men with a clinical suspicion of prostate cancer and could reduce the requirement for biopsies by 30%.
https://growkudos.com/publications/10.3390%25252Fcancers14081995/reader
